Predefined secondary biomarker analysis of 96 patients with ischaemic heart failure in the CONCERT-HF trial: mesenchymal stromal cells, c-kit+ cardiac cells or both vs placebo were associated with selective, time-dependent falls in inflammatory and remodelling biomarkers.
RCTn = 96
Chacon-Alberty et al. Changes in Circulating Biomarkers in Patients With Ischemic Heart Failure After Treatment With Autologous Mesenchymal Stromal Cells and c-Kit-Positive Cardiac Cells, Alone or in Combination: Results From the Cardiovascular Cell Therapy Research Network CONCERT-HF Clinical Trial